Priya Singhal
Corporate Officer/Principal at BIOGEN INC.
Net worth: 1 M $ as of 2024-03-30
Profile
Priya Singhal is currently the Chief Medical Officer at Biogen, Inc. She previously worked as the Head-Medical Affairs & Vice President at Vertex Pharmaceuticals, Inc. from 2008 to 2012.
She also held a position as the Head-Research & Development at Zafgen, Inc. Dr. Singhal holds a doctorate degree from the University of Mumbai and a graduate degree from Harvard T.H.
Chan School of Public Health.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BIOGEN INC.
0.00% | 2024-04-01 | 4,886 ( 0.00% ) | 1 M $ | 2024-03-30 |
Priya Singhal active positions
| Companies | Position | Start |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 2023-10-01 |
Former positions of Priya Singhal
| Companies | Position | End |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Chief Tech/Sci/R&D Officer | 2011-12-31 |
| LARIMAR THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Priya Singhal
| University of Mumbai | Doctorate Degree |
| Harvard T.H. Chan School of Public Health | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| BIOGEN INC. | Health Technology |
| Private companies | 1 |
|---|---|
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Priya Singhal
